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Temperament, although an ancient concept, seems to go
far beyond modern classification systems and utilizes a
wealth of valuable information including personal and
family history as well as ‘non-typical’ symptoms. Thus, it
succeeds to define both the specific features of the individ-
ual mood episode as well as the long term outcome of the
disease, and particularly the response to treatment and
overall outcome. The assessment of the temperament is
not typically utilized when the therapist designs the treat-
ment strategy. The usual practice is to prescribe antide-
pressants for depressive episodes and antipsychotics for
psychotic symptoms; specific antiepileptics and lithium
can be used as mood stablilizers. According to this prac-
tice, the ‘classic’ clinical pictures are easier to recognize
and to treat, and most agents preferably treat with higher
rates of success specific clinical entities, for example lith-
ium is more useful for bipolar patients with euphoric
mania and antidepressants as monotherapy for unipolar
melancholic depression. However, today, the majority of
patients do not fall into these ‘classic’ categories and the
assessment of the temperament can reveal a number of
clues highly predicting response to a specific treatment as
well as the manifestation of a number of problematic
effects of pharmacotherapy like agitation, induction of
mixed states, rapid cycling and suicidality and even weight
gain. Moreover, the knowledge of the temperament can
guide the design of the therapeutic strategy with informed
and careful simultaneous use of multiple agents. This
strategy among others should include some but not all
second generation antipsychotics aiming not to sedate,
but to the fast acute treatment and prophylaxis from
excessive hyperthymic or overt manic behaviours as well
as suicide.
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